Myopia Progression With Freeform Myopia Control Spectacles

Inclusion Criteria: Participants enrolled in the trial must: * be aged between 6 to 12 completed years (6 and 12 years inclusive), irrespective of gender. * For each group, an equal balance of gender will be recruited and 50% of children will be aged between 6- 9 years old and 50% aged 10-12 years old. * be cycloplegic autorefraction spherical component -0.50 D to -4.00D, cylinder no more than -1.50D * be accompanied by parents/guardians who can read and comprehend Chinese and give informed consent as demonstrated by signing a record of informed consent. * be willing to comply with the wearing and clinical trial visit schedule as directed by the Investigator. * have ocular health findings considered to be "normal". * be correctable to at least 6/9.5 (20/30) or better in each eye with spectacles. * be willing to wear the spectacles provided by the investigators for all waking hours. Exclusion Criteria: Participants enrolled in the trial must NOT have: * a known allergy to, or a history of intolerance to tropicamide or topical anaesthetics. * had strabismus and/or amblyopia. * Anisometropia greater than 1.50D spherical equivalent * had previous eye surgery (including strabismus surgery). * any ocular, systemic or other condition or disease with possible associations with myopia or affecting refractive development e.g. Marfan syndrome, retinopathy of prematurity, diabetes. * had any ocular injury or condition (including keratoconus and herpes keratitis) of the cornea, conjunctiva or eyelids. * current orthoptic treatment or vision training. * any anatomical, skin or other condition that would impact on the wearing of spectacles. * Use of or a need for concurrent category S3 and above ocular medication at enrolment and/or during the clinical trial. * Currently enrolled in another clinical trial. * No previous myopia management intervention or treatment within 3 months of enrolment